Insulin and growth factors activate the phosphatidylinositide-3-kinase pathway, leading to stimulation of several kinases including serum-and glucocorticoid-inducible kinase isoform SGK3, a transport regulating kinase. Here, we explored the contribution of SGK3 to the regulation of renal tubular phosphate transport. Coexpression of SGK3 and sodium-phosphate cotransporter IIa significantly enhanced the phosphate-induced current in Xenopus oocytes. In sgk3 knockout and wild-type mice on a standard diet, fluid intake, glomerular filtration and urine flow rates, and urinary calcium ion excretion were similar. However, fractional urinary phosphate excretion was slightly but significantly larger in the knockout than in wild-type mice. Plasma calcium ion, phosphate concentration, and plasma parathyroid hormone levels were not significantly different between the two genotypes, but plasma calcitriol and fibroblast growth factor 23 concentrations were significantly lower in the knockout than in wild-type mice. Moreover, bone density was significantly lower in the knockouts than in wild-type mice. Histological analysis of the femur did not show any differences in cortical bone but there was slightly less prominent trabecular bone in sgk3 knockout mice. Thus, SGK3 has a subtle but significant role in the regulation of renal tubular phosphate transport and bone density.
Insulin and growth factors activate the phosphatidylinositide-3-kinase pathway, leading to stimulation of several kinases including serum-and glucocorticoid-inducible kinase isoform SGK3, a transport regulating kinase. Here, we explored the contribution of SGK3 to the regulation of renal tubular phosphate transport. Coexpression of SGK3 and sodium-phosphate cotransporter IIa significantly enhanced the phosphate-induced current in Xenopus oocytes. In sgk3 knockout and wild-type mice on a standard diet, fluid intake, glomerular filtration and urine flow rates, and urinary calcium ion excretion were similar. However, fractional urinary phosphate excretion was slightly but significantly larger in the knockout than in wild-type mice. Plasma calcium ion, phosphate concentration, and plasma parathyroid hormone levels were not significantly different between the two genotypes, but plasma calcitriol and fibroblast growth factor 23 concentrations were significantly lower in the knockout than in wild-type mice. Moreover, bone density was significantly lower in the knockouts than in wild-type mice. Histological analysis of the femur did not show any differences in cortical bone but there was slightly less prominent trabecular bone in sgk3 knockout mice. Thus, SGK3 has a subtle but significant role in the regulation of renal tubular phosphate transport and bone density. Phosphate is a critically important component of bone minerals.
1,2 Accordingly, adequate mineralization of bone depends on the precise tuning of phosphate balance, which is a function of intestinal absorption and renal excretion. 1, 3, 4 The latter depends on cellular uptake of phosphate across the apical membrane of proximal tubular cells, 5 which is mainly accomplished by the Na þ -coupled phosphate transporter NaPiIIa. 3, 5 The carrier is downregulated by parathyroid hormone (PTH), 3 a hormone at least in part effective through cyclic adenosine monophosphate. In contrast, renal tubular phosphate reabsorption is stimulated by insulin 6, 7 and insulin-like growth factor IGF1. 8, 9 Little is known, however, about the signaling involved in the insulin-and IGF1-mediated regulation of phosphate excretion.
The signaling of insulin involves the serum-and glucocorticoid-inducible kinase SGK3, 10 which, similar to protein kinase B 11 and SGK1, 12 is activated by phosphatidylinositol-3-kinase and phosphoinositide-dependent kinase PDK1. SGK3 is known to regulate a wide variety of transport systems. 13 The present study thus explored the possibility that SGK3 may be involved in the regulation of renal tubular transport. To this end, the in vitro regulation of NaPiIIa by SGK3 was studied in the heterologous Xenopus oocyte expression system and in vivo significance of SGK3-sensitive phosphate transport elucidated by analyzing gene-targeted mice lacking functional SGK3 (sgk3 KO ) as well as wild-type mice (sgk3 WT ).
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RESULTS
A first series of experiments analyzed the in vitro influence of the serum-and glucocorticoid-inducible kinase isoform SGK3 on NaPiIIa, the major renal tubular phosphate transporter. Exposure of non-injected Xenopus oocytes to phosphate (3 mmol/l) in the bath solution did not induce a significant current, indicating that these oocytes do not express significant endogenous electrogenic phosphate transport ( Figure 1a ). In oocytes injected with complementary RNA encoding NaPiIIa, however, the addition of phosphate (3 mmol/l) induced an inward current (I Pi ; Figure 1a ). Coexpression of SGK3 significantly increased I Pi in NaPiIIaexpressing oocytes (Figure 1a) . Expression of SGK3 alone did not induce I Pi , indicating that SGK3 was indeed effective by stimulating NaPiIIa. The membrane abundance of NaPiIIa in oocytes was determined by a chemiluminiscence-based assay.
As shown in Figure 1b , coexpression of SGK3 significantly increased the surface expression of NaPiIIa to a similar extent as it stimulated phosphate-induced currents. Experiments in brush border membrane vesicle (BBMV) preparations from sgk3 KO and sgk3 WT mice were performed to determine the sodium-dependent transport of phosphate ex vivo. However, no significant difference in total and phosphonoformic acid (6 mmol/l)-resistant transport was observed between sgk3 KO and sgk3 WT mice (Figure 2) . Similarly, the protein expression of the phosphate transporters NaPiIIa, NaPiIIc, and Pit2 in brush border membrane fractions was not different between the genotypes (Figure 2 Figure 3) . Similarly, the plasma glucose concentration was not significantly different between genotypes (data not shown).
The urinary flow rate and creatinine clearance tended to be slightly higher in sgk3 KO mice than in sgk3 WT mice, a difference, however, not reaching statistical significance ( Table 1 ). The absolute (Table 1 ) and fractional ( Figure 3 ) excretions of Ca 2 þ were not significantly different between the two genotypes. In contrast, the absolute (Table 1) and fractional ( Figure 3 ) excretions of phosphate were significantly higher in sgk3 KO mice than in sgk3 WT mice. In neither the sgk3 WT nor the sgk3 KO mice, glucosuria was observed (data not shown).
The renal phosphate excretion was further studied under a low-phosphate diet. The urinary phosphate excretion was still significantly higher in sgk3 KO (0.17±0.03 mmol/24 h per g body weight; n ¼ 5) than in sgk3 WT (0.10±0.01 mmol/24 h per g body weight; n ¼ 6) mice. To further analyze the renal function of those mice, acute inulin clearance studies were performed under anesthesia. The glomerular filtration rate (GFR) as determined from the inulin clearance was not significantly different between sgk3
WT (119 ± 28 ml/min; n ¼ 5) and sgk3 KO (92 ± 22 ml/min; n ¼ 5) mice. In this series, the fractional excretion of phosphate was again higher in sgk3 KO (2.4±0.3%) than in sgk3 WT (1.7±0.1%) mice. The phosphaturia could have been secondary to altered levels of hormones involved in phosphate homeostasis. Therefore, the plasma levels of PTH, calcitriol (1,25(OH) 2 D 3 ) and fibroblast growth factor 23 (FGF 23) were determined. As illustrated in Figure 4 , the PTH plasma concentration was not significantly different between the genotypes, whereas the plasma 1,25(OH) 2 D 3 and plasma FGF23 concentrations were significantly lower in sgk3 KO mice compared with sgk3 WT mice. The renal loss of phosphate is expected to foster demineralization of bone. Thus, the bone density was determined in sgk3 KO and sgk3 WT mice. As shown in Figure 5a , the bone density was indeed lower in sgk3 KO than in sgk3 WT mice. A histological analysis of the femur showed no obvious differences in the cortical bone between the two genotypes but revealed that the trabecular bone appeared to be less prominent in sgk3 KO mice than in sgk3 WT mice (Figure 5b ).
DISCUSSION
The present observations disclose a novel function of SGK3, that is, stimulation of renal tubular phosphate transport. According to the experiments on Xenopus oocytes, coexpression of SGK3 increases NaPiIIa activity. The in vivo relevance of SGK3-sensitive NaPiIIa regulation is underscored by the mild phosphaturia of sgk3 KO mice. The phosphaturia of sgk3 KO mice was not due to an increased plasma phosphate concentration and occurs without significant alterations of the PTH plasma concentration. The hormone is well known to downregulate renal phosphate transport, 3 and its release is stimulated by an enhanced plasma phosphate concentration. 15 The plasma levels of 1,25(OH) 2 D 3 were significantly decreased in sgk3 KO mice. The rate-limiting enzyme in the generation of 1,25(OH) 2 D 3 is the renal 1a-hydroxylase, 16, 17 which is stimulated by PTH We did not observe a significant decrease of the plasma phosphate concentration despite the mild phosphaturia. Enhanced phosphate excretion must thus be paralleled by enhanced intestinal phosphate absorption or phosphate loss from bone. In an earlier study, fecal phosphate excretion was not significantly different between SGK3 KO and sgk3 WT mice. 23 However, the food intake was significantly higher in sgk3 KO mice than in sgk3 WT mice, and thus intestinal phosphate absorption might indeed have been increased.
The phosphaturia of sgk3 KO mice was not paralleled by a decrease of phosphate transport across BBMVs or of mRNA and protein abundance of the phosphate transporters. The lack of significant differences between tissue of sgk3 WT mice and sgk3
KO mice is at seeming contrast to the powerful effect of SGK3 on NaPiIIa expression in Xenopus oocytes. It must be kept in mind, although, that the in vivo effect of SGK3 is paralleled by a similar effect of PKB/Akt, 24 and thus knockout of one of the kinases in mice does not abrogate SGK3/PKB/ AKT-dependent regulation of NaPiIIa and is thus not expected to yield similarly strong effects as overexpression of SGK3 in Xenopus oocytes. The mild phosphaturia of sgk3 KO mice confirms that SGK3 indeed participates in the regulation of renal tubular phosphate reabsorption. It remains elusive, although, why the phosphaturia is not reflected by respective alterations of carrier protein abundance and phosphate uptake in brush border vesicles. Possibly, SGK3 does not only affect NaPiIIa abundance in a heterologous expression system such as oocytes, but may also stimulate the activity of phosphate transporter in vivo without altering their cell surface expression.
The sgk3 KO mice suffer from a subtle but significant decrease of bone mass, which may again be partially due to decreased formation of 1,25(OH) 2 D 3. The 1,25(OH) 2 D 3 is known to counteract apoptosis of osteoblasts 25 and thus enhances bone mineralization. 26 The effect of 1,25(OH) 2 in osteoblasts is mediated by the phosphoinositide-3-kinase pathway, 27 and may thus involve at least partially SGK3. The demineralization of bone may further be due to phosphate depletion, as phosphate inhibits the formation of new osteoclasts and stimulates apoptosis of mature osteoclasts. 28 The present observations do not rule out the participation of further mechanisms. For instance, SGK3 shares several functions with Akt2/PKBb, 29 which has been shown to confer survival of osteoblasts 30 and osteoclasts. 31, 32 In conclusion, the present observations reveal a novel function of SGK3, that is, its involvement in the regulation of 1,25(OH) 2 D 3 plasma concentration, renal phosphate excretion, and mineralization of bone.
MATERIALS AND METHODS
In vitro experiments
For generation of complementary RNA, constructs were used encoding wild-type human NaPiIIa 33 and human SGK3. 10 The complementary RNA was generated as described previously.
34 SGK3 cDNA was kindly provided by Sir Philip Cohen (MRC Protein Phosphorylation Unit, Dundee) and the cDNA encoding NaPiIIa by Heini Murer, (University of Zurich, Zurich). For electrophysiology, Xenopus oocytes were prepared as previously described. 35, 36 Wildtype SGK3 (7.5 ng) and 15 ng of NaPiIIa complementary RNA were injected on the same day after preparation of Xenopus oocytes. All experiments were performed at room temperature 4-5 days after injection. Two electrode voltage-clamp recordings were performed at a holding potential of À50 mV. 37 The data were filtered at 10 Hz and recorded with a Digidata A/D-D/A converter and Chart V.4.2 software for data acquisition and analysis (Axon Instruments, Berlin, Germany). 38 The control solution (superfusate/ND96) contained 96 mmol/l NaCl, 2 mmol/l KCl, 1.8 mmol/l CaCl 2 , 1 mmol/l MgCl 2 , and 5 mmol/l HEPES, pH 7.4. Phosphate (2 mmol/l) was added to induce NaPiIIa-dependent currents. The flow rate of the superfusion was 20 ml/min, and a complete exchange of the bath solution was reached within about 10 s. All experiments were repeated with at least three batches of oocytes; in all repetitions, qualitatively similar data were obtained.
Detection of NaPiIIa cell surface expression by chemiluminescence Defolliculated oocytes were incubated with primary rabbit antiNaPiIIa antibody (diluted 1:500, Lifespan Biosciences, Seattle, WA) and secondary, peroxidase-conjugated goat anti-rabbit antibody (diluted 1:1000, Cell Signaling, Danvers, MA). Individual oocytes were placed in 96-well plates with 10 ml of Super Signal ELISA Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL). Chemiluminescence of single oocytes was quantified in a luminometer (WalterWallac2 plate reader, Perkin Elmer, Jügesheim, Germany) by integrating the signal over a period of 1 s. Results display normalized arbitrary light units that are proportional to the detector voltage.
In vivo function
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities.
Generation and basic properties of the SGK3 knockout mice (sgk3 KO ) were described previously. 39 The mice were compared with the wild-type mice (sgk3 WT ) and genotyped by PCR on tail DNA using SGK3-and neoR-specific primers as previously described. 39 The mice (age 3.5-6 months) were fed a control diet containing 0.7% phosphate (C1314, Altromin, Lage, Germany) or 7-day-lowphosphate diet containing less than 0.1% phosphate (C 1048 Altromin, Germany) with free access to tap drinking water.
For evaluation of renal excretion, both sgk3 KO and sgk3 WT mice were placed individually in metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24-h urine collection, as described previously. 40 They were allowed a 3-day habituation period during which food and water intake, urinary flow rate, urinary excretion of salt, fecal excretion, and body weight were recorded every day to ascertain that the mice were adapted to the new environment. Subsequently, 24-h collection of urine was performed for several consecutive days to obtain the urinary parameters. To assure quantitative urine collection, metabolic cages were siliconized, and urine was collected under water-saturated oil.
To obtain blood specimens, animals were lightly anesthetized with diethylether (Roth, Karlsruhe, Germany), and about 150 ml of KO than in sgk3 WT mice.
blood was withdrawn into heparinized capillaries by puncturing the retro-orbital plexus. Urinary phosphate concentration was determined colorimetrically utilizing a commercial diagnostic kit (Roche Diagnostics, Mannheim, Germany). Plasma and urinary calcium, and plasma phosphate concentration were determined by a photometric method according to the manufacturer's instructions (dri-chem clinical chemistry analyzer FUJI FDC 3500i, Sysmex, Norsted, Germany). Creatinine concentration in urine was determined using the Jaffe reaction (Sigma, St Louis, MO), creatinine concentration in serum was measured using an enzymatic kit (creatinine PAP, Lehmann, Berlin, Germany) according to the manufacturer's instructions. Plasma PTH concentration was measured using an ELISA kit (Immunotopics, San Clemente, CA). A radioimmunoassay kit was employed to determine the concentration of 1,25(OH) 2 -vitamin D 3 (IDS, Boldon, UK) in plasma. Plasma FGF23 was determined using an ELISA kit (Immunotopics, San Clemente, CA).
Clearance experiments
Clearance experiments were performed in anaesthetized SGK3 wildtype and knockout mice (n ¼ 5 in each group), as described previously. 41, 42 Briefly, mice were anesthetized intraperitoneally with 80 mg/kg sodium pentobarbital. Body temperature was maintained at 37.5 1C by placing the animals on an operating table with a servocontrolled heating plate. The trachea was cannulated for free air breathing throughout the experiment. The left femoral artery was cannulated for arterial blood pressure recording and blood sample withdrawal. The right jugular vein was cannulated for continuous maintenance infusion of 0.85% NaCl at a rate of 8 ml/min. For assessment of GFR, [3H]-inulin was added into 0.85% NaCl solution to deliver 20 mCi/h radioactive inulin. Urine samples were collected via a catheter inserted into the urinary bladder. After surgical preparation, mice were allowed to stabilize for 20 min. Subsequently, to determine renal function, a 60-min urine collection period was performed. Blood samples (80 ml) were collected immediately before and after urine collections. Blood pressure was recorded before every blood sample collection. Urinary flow rate was determined gravimetrically. Concentrations of [3H]inulin in plasma and urine were measured by liquid-phase scintillation counting. The glomerular filtration rate was calculated according to standard formulas.
Brush border membrane preparation and phosphate transport assays BBMVs were prepared from mice kidney cortex and outer medulla using the Mg 2 þ precipitation technique, as described previously. 43 The phosphate transport rate into BBMVs was measured in freshly prepared BBMV at 25 1C in the presence of inward gradients of 100 mmol/l NaCl or 100 mmol/l KCl and 0.1 mmol/l K phosphate. The substrate inorganic phosphate was made with 0.125 mmol/l K 2 HPO 4 and 32 P (1 mCi/ml) to yield a final concentration 0.1 mmol/ l close to the expected apparent KmPi for Na þ -dependent transport in renal BBMVs. The stop solution contained 100 mmol/l mannitol, 5 mmol/l Tris-HCl, pH 7.4, 150 mmol/l NaCl, and 5 mmol/l inorganic phosphate. Na þ dependence was established by incubating BBMVs in solutions in which KCl replaced NaCl equimolarly. Phosphate uptake was determined after 60 s, representing initial linear conditions, and after 120 min, to determine the equilibrium values. To distinguish between Na þ -dependent inorganic phosphate uptake mediated by SLC34 family members (for example, NaPiIIa and NaPiIIc) and other Na þ -dependent phosphate transporters, such as SLC20 family members (for example, Pit1 and Pit2), trisodium phosphonoformic acid (final concentration 6 mmol/l) added to the same solution with 107 mmol/l NaCl was used. Phosphonoformic acid has previously been shown to have a higher selectivity for SLC34 than SLC20 phosphate transporters at this concentration. 44 The total protein concentration was measured using the Bio-Rad Protein Assay kit; Bio-Rad, Hercules, CA. BBMVs were stored at À80 1C until further use.
Western blotting
After measurement of the protein concentration (Bio-Rad), 10 mg of renal brush border membrane proteins was solubilized in loading buffer containing dithiothreitol and separated on 8% polyacrylamide gels. For immunoblotting, the proteins were transferred electrophoretically to polyvinylidene fluoride membranes (Immobilon-P, Millipore, Bedford, MA). After blocking with 5% milk powder in Tris-buffered saline/0.1% Tween-20 for 60 min, the blots were incubated with the primary antibodies: rabbit polyclonal antiNaPiIIa (1:6000) 45 rabbit polyclonal anti-NaPiIIc (1:10,000), 46 rabbit polyclonal anti-Pit2 (1:3000; kindly provided by Dr V Sorribas, University of Zaragosa, Spain), 44 and mouse monoclonal anti-b-actin antibody (42 kD; Sigma; 1:5000) either for 2 h at room temperature or overnight at 4 1C. Membranes were then incubated for 1 h at room temperature with secondary goat anti-rabbit or donkey anti-mouse antibodies (1:5000) linked to alkaline phosphatase (Promega, Madison, WI) or HRP (Amersham, Freiburg, Germany). The protein signal was detected with the appropriate substrates (Millipore) using the DIANA III-chemiluminescence detection system (Raytest, Straubenhardt, Germany). All images were analyzed using the software Advanced Image Data Analyser AIDA (Raytest) to calculate the protein of interest/b-actin ratio.
Determination of bone density
For the analysis of bone density, animals were killed and hind legs were removed and fixed in formalin. The samples were scanned with a high-resolution microCAT-II (Siemens, München, Germany) small-animal-computed tomography scanner using a field of view of 3.1 Â 3.1 Â 4.8 cm 3 . The X-ray tube parameters were set at 80 kVp and 400 mA. The images were acquired with 720 angular projections (exposure time 1200 ms per projection) over 3601 and binned with a factor of two, yielding a spatial resolution of B38 mm. The total scan time was 24 min. Reconstructed computed tomography images were analyzed with the Inveon Research Workplace software (Siemens) by drawing a standard-sized area around the femur and applying a region growth routine to segment the trabecular bone structure. For all samples, the same upper-and lower-density thresholds were applied comparing the relative numbers of trabecular bone density.
Bone histology
For morphological bone analysis, femurs of sgk3 KO and sgk3 WT mice (n ¼ 5-6 in each group) were fixed in 4.5% buffered formalin (RotiHistofix 4.5%, Roth, Karlsruhe, Germany) for at least 24 h. Decalcification was performed in EDTA solution at room temperature for 2-3 days. The decalcified bones were embedded in paraffin and cut in 2-to 3-mm thick sections and stained with hematoxylin and eosin.
Statistical analysis
Data are provided as arithmetic means ± s.e.m., n represents the number of independent experiments. All data were tested for significance using analysis of variance (Figure 1 ) or paired or unpaired Student's t-test. Only results with Po0.05 were considered statistically significant.
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